Statement from The Association for Frontotemporal Degeneration on the Need for Robust and Consistent Medical Research Funding

The Association for Frontotemporal Degeneration (AFTD) continues to urgently advocate for robust and consistent funding for the National Institutes of Health (NIH) in FY 2026 appropriations. Despite being the most common dementia diagnosed in people under 60 years, FTD currently has no effective treatment to prevent its onset and slow its progression. Families and their…

Read More

AFTD Joins Nearly 150 Supporters in Letter Urging Congress to Reject Medicaid and SNAP Cuts

Title Text: AFTD Joins Nearly 150 Supporters in Letter Urging Congress to Reject Medicaid and SNAP Cuts | Background: AFTD logo and Alliance for Aging Research logo

AFTD joined nearly 150 organizations and individuals in a letter penned by the Alliance for Aging Research urging congressional leaders to reject proposed cuts to Medicaid and the Supplemental Nutrition Assistance Program (SNAP). These cuts would have a significant impact on the well-being of families affected by FTD, Alzheimer’s disease, and other dementias, the letter…

Read More

Advancing Hope: AFTD Hosts 2025 Holloway Summit

Text: Advancing Hope - AFTD Hosts 2025 Holloway Summit | Background: A photo from the 2025 Holloway Summit with attendees watching a presentation

Can the risk of developing FTD be changed by environmental exposures, lifestyle, diet, and other factors? Are the genetic risks fully understood? These questions are regularly asked by affected families and at-risk individuals. On January 22-24, 2025, the third annual AFTD Holloway Summit convened academic scientists, nonprofit partners, persons with lived experience, and AFTD staff…

Read More